Healthcare Reform

Patient Safety Movement Foundation’s Mid-Year Meeting Charts Course for Global Patient Safety Initiatives in 2024

Retrieved on: 
Saturday, January 27, 2024
Nursing, Public Policy, Government, Health, Healthcare Reform, Hospitals, Health Insurance, General Health, Momentum, Patient safety, World Health Organization, Patient, Hospital, Cause of action, Open data, Evidence-based medicine, Multimedia, ApiJect Systems, Summit, Competition, University, Algorithm, Johns Hopkins, PCAST, PSMF, Safety, Public health, ZERO, Approximation error

The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare system that result in millions of preventable deaths around the world.

Key Points: 
  • The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare system that result in millions of preventable deaths around the world.
  • View the full release here: https://www.businesswire.com/news/home/20240126619652/en/
    Patient Safety Movement Foundation Founder Joe Kiani speaks about the road ahead in global efforts to eliminate preventable patient harm at the PSMF's annual Mid-Year Event.
  • In 2012, Joe Kiani founded the non-profit Patient Safety Movement Foundation (PSMF) to eliminate preventable medical errors in hospitals.
  • His team worked with patient safety experts from around the world to create Actionable Evidence-Based Practices (AEBP) that address the top challenges.

AHF Applauds Sen. Wiener’s PBM Abuse Bill

Retrieved on: 
Friday, January 26, 2024
AIDS, Other Health, Health, General Health, State, Local, Healthcare Reform, Pharmaceutical, Other Policy Issues, Infectious Diseases, Public Policy, Government, Advocacy Group Opinion, AIDS Healthcare Foundation, Patient, Legislation, Pharmacist, AHF, Pharmacy

“Pharmacy benefit managers, or PBMs, have operated too long in the shadows, interfering with patient access to care, starving pharmacy providers, creating pharmacy deserts while they rake in massive profits that inflate healthcare costs.

Key Points: 
  • “Pharmacy benefit managers, or PBMs, have operated too long in the shadows, interfering with patient access to care, starving pharmacy providers, creating pharmacy deserts while they rake in massive profits that inflate healthcare costs.
  • California patients deserve and need better.”
    AHF has been working closely with the CA Pharmacists Association for more than a year on this, and it is a high priority for AHF's California legislative agenda.
  • AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 1.9 million individuals across 45 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe.
  • To learn more about AHF, visit us online at AIDShealth.org , find us on Facebook , follow us on Instagram , Twitter , and TikTok , and subscribe to our AHFter Hours podcast.

Cross-Border Impact Ventures Exceeds $90 Million in Final Close of Its Women’s and Children’s Health Technology Fund

Retrieved on: 
Thursday, January 25, 2024
Women, Technology, General Health, Public Policy, Government, Consumer, Other Professional Services, Healthcare Reform, Children, Finance, Banking, Professional Services, Other Technology, Philanthropy, Artificial Intelligence, Software, Health, Fund Raising, Foundation, Internet, Hardware, Mortality, SIDA, Hamilton Community Foundation, Woman, Machine learning, Patient, Artificial intelligence, Software as a service, Incubator, Cancer, Fund, Investment, Cervical cancer, Pregnancy, Grand Challenges Canada, Partner (business rank), Medtech, FDA, CE marking, HPV

The Fund also benefits from a guarantee provided by the Swedish International Development Cooperation Agency ( SIDA ).

Key Points: 
  • The Fund also benefits from a guarantee provided by the Swedish International Development Cooperation Agency ( SIDA ).
  • CBIV invests in health technology companies with global growth, high return, and impact potential.
  • Its primary focus is on medical device, diagnostic, and digital health companies based in North America and Europe that are globally relevant, including in emerging markets.
  • We bring in industry and clinical experts from our international network to unlock growth and impact,” said Donna Parr, Managing Partner at CBIV.

HomeWell Care Services Recognized a Top Franchise of 2024 in Entrepreneur’s 45th Franchise 500®

Retrieved on: 
Thursday, January 25, 2024
Professional Services, Health, General Health, Women, Healthcare Reform, Public Relations, Investor Relations, Seniors, Small Business, Communications, Public Policy, Government, Consumer, Growth, Franchise, Video game

HomeWell Care Services was recognized as one of the top 500 franchises in Entrepreneur magazine's 2024 Franchise 500®, a highly sought-after recognition in the franchise industry.

Key Points: 
  • HomeWell Care Services was recognized as one of the top 500 franchises in Entrepreneur magazine's 2024 Franchise 500®, a highly sought-after recognition in the franchise industry.
  • "We are honored to be recognized once again in Entrepreneur's prestigious Franchise 500,” said Crystal Franz, CEO of HomeWell Franchising.
  • HomeWell Care Services®, franchised by HomeWell Franchising Inc., provides personal care, companionship, and homemaker services for seniors and other homebound individuals so they can remain safely in the comfort of wherever they call home.
  • For more information on HomeWell or to explore franchise opportunities, visit HomeWell Care Services or HomeWell Care Services Franchising .

APIIC Releases Recommendations to Combat Rising U.S. Drug Shortages and Ensure Access to Life-Saving Medications

Retrieved on: 
Wednesday, January 24, 2024
Public Policy, Government, Health, Healthcare Reform, Logistics, Supply Chain Management, Transport, General Health, Pharmaceutical, Molecule, Small molecule, Policy, National Economic Council, API, Thermo Fisher Scientific, USP, Joe Biden, APIIC, NSA, Olin Business School, NEC, Health policy, Organization, Workforce, MacNamara, Fine chemical

“The collaboration necessary to develop a paper of this caliber is impressive,” said Tony Sardella, chair of the API Innovation Center.

Key Points: 
  • “The collaboration necessary to develop a paper of this caliber is impressive,” said Tony Sardella, chair of the API Innovation Center.
  • The APIIC report encourages pharmaceutical manufacturers and policy makers to address these vulnerabilities to national health security through the adoption of advanced biomanufacturing technologies and public incentive programs designed to reignite idle capacity at U.S. manufacturing facilities.
  • “For more than 200 years, U.S. Pharmacopeia has brought healthcare professionals, scientists, and regulators together to ensure quality and trust in our drugs,” said Dennis Hall, vice president, Advanced Manufacturing Technologies at U.S. Pharmacopeia (USP).
  • It follows developments and reports from the White House Office of Science and Technology , the National Economic Council (NEC) Director and the National Security Advisor (NSA), calling for a new approach aimed at guaranteeing Americans reliable access to essential medications.

TARA Mind Announces $8 Million in Seed Funding to Expand Affordable Access to Life-Changing Mental Health Therapeutics

Retrieved on: 
Tuesday, January 23, 2024
Pharmaceutical, Health Insurance, Other Science, Mental Health, Research, Healthcare Reform, Public Policy, Government, Other Professional Services, Insurance, Human Resources, Finance, Alternative Medicine, Other Consumer, Professional Services, Health, Women, Men, General Health, Veterans, Science, Consumer, People with Disabilities, Other Health, Family, Navy, TARA, Culture, Absenteeism, Mental health, Therapy, Workforce, Data, KAT, ROI, Pharmaceutical industry

Additional investors participating in the oversubscribed round were Echo Investment Capital, Crumpton Ventures, Empath Ventures, and Blake Mykoskie: Founder of TOMS.

Key Points: 
  • Additional investors participating in the oversubscribed round were Echo Investment Capital, Crumpton Ventures, Empath Ventures, and Blake Mykoskie: Founder of TOMS.
  • The Company has developed a first of its kind mental health collaborative care platform, recognized for being clinician-guided, data-driven and evidence-based, to help the millions of individuals struggling with mental health disorders that have not been clinically responsive to traditional mental health therapies.
  • Through its provider collaborative care platform, TARA Mind is able to administer highly effective, clinician-guided personalized mental health treatments and incorporate them into today’s employer funded benefit plans.
  • Marcus Capone, CEO of TARA Mind, stated, “As a Navy SEAL, I was fortunate to not face affordability or access challenges to available treatments for my deteriorating mental health.

Sandata Launches Fuse Homecare Agency Management; Empowering Homecare Agencies with Intuitive User Experience and Advanced Functionality

Retrieved on: 
Friday, January 19, 2024
Public Policy, Government, Health, Healthcare Reform, Technology, Health Insurance, Software, General Health, EVV, Fuse, Electronic visit verification, Communication

Sandata, the pioneering force in home and community-based care, today announced the launch of Sandata Fuse™ Agency Management.

Key Points: 
  • Sandata, the pioneering force in home and community-based care, today announced the launch of Sandata Fuse™ Agency Management.
  • It represents a leap in agency management, empowering agencies to navigate this complexity with ease and efficiency.
  • "With Fuse, we're redefining the way homecare agencies operate,” said Raj Bhavsar, Chief Technology Officer of Sandata.
  • "Fuse Agency Management marks a significant milestone in our journey to empower homecare agencies,” said Emmet O’Gara, Chief Executive Officer of Sandata.

Erin O’Malley Named Executive Director of the Coalition for Trust in Health & Science

Retrieved on: 
Thursday, January 18, 2024
Public Policy, Government, General Health, Health, Other Policy Issues, Healthcare Reform, Public Safety, Other Health, Distrust, Policy, Multimedia, Health equity, Partnership, AARP, Trust, Coalition, University, Transition, Georgetown University, Nursing, Strategic planning, Health literacy, Organization, Doctor of Philosophy, CTHS

The Coalition for Trust in Health & Science (CTHS) today announced the appointment of Erin O’Malley as executive director.

Key Points: 
  • The Coalition for Trust in Health & Science (CTHS) today announced the appointment of Erin O’Malley as executive director.
  • The Coalition brings together leading organizations from across the health ecosystem to advance trustworthiness in health, medical care relationships and factual, science-backed, decision-making.
  • View the full release here: https://www.businesswire.com/news/home/20240118588706/en/
    Erin O’Malley, executive director, The Coalition for Trust in Health & Science (Photo: Business Wire)
    “Ms.
  • Members pledge to support efforts to advance people’s scientific and health literacy, earn public trust and improve health outcomes and health equity, and work individually and collectively to correct and counter misinformation that threatens people’s health and well-being.

New Study Reinforces That Expansion of IRA Price Setting Would Further Crush Patient Health, Innovative Treatments and U.S. Biopharma Jobs

Retrieved on: 
Thursday, January 18, 2024
Public Policy, Government, Health, Healthcare Reform, Research, Science, Pharmaceutical, Biotechnology, Patient, House, Policy, Medicare, Partnership, IRA, Initial public offering, Infection, Investment, Congress, Statistics, Brain, Ageing, Unemployment, Pharmaceutical industry

Since 2021, venture capital investments in biopharma have dropped by 50% and IPOs for biopharma firms by 70% – with an outsized impact on investments targeting cancer treatments.

Key Points: 
  • Since 2021, venture capital investments in biopharma have dropped by 50% and IPOs for biopharma firms by 70% – with an outsized impact on investments targeting cancer treatments.
  • A new study from research firm Vital Transformation warns of further decline in new treatments for patients – particularly seniors – if lawmakers act on plans to expand government price controls.
  • One proposal by some House Democrats would impose price setting for up to 50 selected Medicare drugs starting in 2029 and expand those negotiated prices to the commercial market.
  • Amid mass layoffs and rising unemployment, these policies could cost the nation more than 1 million U.S. biopharmaceutical industry jobs.

Record $765B in Federal Contracts Awarded in 2023 – HigherGov Report

Retrieved on: 
Wednesday, January 17, 2024
Other Policy Issues, Labor, Other Defense, Homeland Security, Contracts, Congressional News, Views, Aerospace, Public Policy, Government, Manufacturing, Defense, Commercial Building & Real Estate, Construction & Property, Law Enforcement, Emergency Services, Other Professional Services, Healthcare Reform, Small Business, Government Technology, Professional Services, White House, Federal Government, Growth, Arms industry

A new report by government market intelligence platform HigherGov shows that defense and civilian contractors were awarded a record level of contract awards in 2023.

Key Points: 
  • A new report by government market intelligence platform HigherGov shows that defense and civilian contractors were awarded a record level of contract awards in 2023.
  • The 2023 Federal Contract Award Report , based on analysis of public and proprietary HigherGov data, found that federal prime contractors received a total of $765 billion in awards.
  • Competition levels reached a record high in 2023, with an average of 3.4 bidders per award
    “Strong growth in 2023 was primarily attributable to spending on the war in Ukraine, large defense procurement programs and broad-based award growth,” said Justin Siken, founder of HigherGov.
  • 2023 award levels benefited significantly from procurement programs and war spending that may not be repeated in the future.